Literature DB >> 29093266

Macrophage-derived oncostatin M contributes to human and mouse neurogenic heterotopic ossifications.

Frédéric Torossian1, Bernadette Guerton1, Adrienne Anginot1, Kylie A Alexander2, Christophe Desterke3, Sabrina Soave1, Hsu-Wen Tseng2, Nassim Arouche1, Laetitia Boutin1, Irina Kulina2, Marjorie Salga2,4, Beulah Jose2, Allison R Pettit2, Denis Clay3, Nathalie Rochet5, Erica Vlachos6, Guillaume Genet6, Charlotte Debaud4,6, Philippe Denormandie6, François Genet4,6, Natalie A Sims7, Sébastien Banzet1,8, Jean-Pierre Levesque2, Jean-Jacques Lataillade1,8, Marie-Caroline Le Bousse-Kerdilès1.   

Abstract

Neurogenic heterotopic ossification (NHO) is the formation of ectopic bone generally in muscles surrounding joints following spinal cord or brain injury. We investigated the mechanisms of NHO formation in 64 patients and a mouse model of spinal cord injury-induced NHO. We show that marrow from human NHOs contains hematopoietic stem cell (HSC) niches, in which mesenchymal stromal cells (MSCs) and endothelial cells provide an environment supporting HSC maintenance, proliferation, and differentiation. The transcriptomic signature of MSCs from NHOs shows a neuronal imprinting associated with a molecular network required for HSC support. We demonstrate that oncostatin M (OSM) produced by activated macrophages promotes osteoblastic differentiation and mineralization of human muscle-derived stromal cells surrounding NHOs. The key role of OSM was confirmed using an experimental model of NHO in mice defective for the OSM receptor (OSMR). Our results provide strong evidence that macrophages contribute to NHO formation through the osteogenic action of OSM on muscle cells within an inflammatory context and suggest that OSM/OSMR could be a suitable therapeutic target. Altogether, the evidence of HSCs in ectopic bones growing at the expense of soft tissue in spinal cord/brain-injured patients indicates that inflammation and muscle contribute to HSC regulation by the brain-bone-blood triad.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29093266      PMCID: PMC5752299          DOI: 10.1172/jci.insight.96034

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  71 in total

1.  The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor.

Authors:  D P Gearing; M R Comeau; D J Friend; S D Gimpel; C J Thut; J McGourty; K K Brasher; J A King; S Gillis; B Mosley
Journal:  Science       Date:  1992-03-13       Impact factor: 47.728

Review 2.  Making sense of hematopoietic stem cell niches.

Authors:  Philip E Boulais; Paul S Frenette
Journal:  Blood       Date:  2015-03-11       Impact factor: 22.113

3.  Oncostatin M reduces lesion size and promotes functional recovery and neurite outgrowth after spinal cord injury.

Authors:  Helena Slaets; Sofie Nelissen; Kris Janssens; Pia M Vidal; Evi Lemmens; Piet Stinissen; Sven Hendrix; Niels Hellings
Journal:  Mol Neurobiol       Date:  2014-07-05       Impact factor: 5.590

Review 4.  The brain-bone-blood triad: traffic lights for stem-cell homing and mobilization.

Authors:  Tsvee Lapidot; Orit Kollet
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2010

5.  Prospective heterotopic ossification progenitors in adult human skeletal muscle.

Authors:  Jennifer Downey; Dominique Lauzier; Peter Kloen; Klaus Klarskov; Martin Richter; Reggie Hamdy; Nathalie Faucheux; Anthony Scimè; Frédéric Balg; Guillaume Grenier
Journal:  Bone       Date:  2014-11-01       Impact factor: 4.398

6.  Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells.

Authors:  H J Sutherland; C J Eaves; P M Lansdorp; J D Thacker; D E Hogge
Journal:  Blood       Date:  1991-08-01       Impact factor: 22.113

7.  Prostaglandin E2 is a novel inducer of oncostatin-M expression in macrophages and microglia.

Authors:  Pavle Repovic; Etty N Benveniste
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

8.  Expansion and differentiation of CD14+CD16(-) and CD14+ +CD16+ human monocyte subsets from cord blood CD34+ hematopoietic progenitors.

Authors:  Malgorzata Stec; Kazimierz Weglarczyk; Jaroslaw Baran; Ewa Zuba; Bozenna Mytar; Juliusz Pryjma; Marek Zembala
Journal:  J Leukoc Biol       Date:  2007-06-26       Impact factor: 4.962

9.  Oncostatin M maintains the hematopoietic microenvironment in the bone marrow by modulating adipogenesis and osteogenesis.

Authors:  Fumi Sato; Yuichiro Miyaoka; Atsushi Miyajima; Minoru Tanaka
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

10.  Osteogenic differentiation capacity of human skeletal muscle-derived progenitor cells.

Authors:  Teruyo Oishi; Akiyoshi Uezumi; Arihiko Kanaji; Naoki Yamamoto; Asami Yamaguchi; Harumoto Yamada; Kunihiro Tsuchida
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

View more
  30 in total

1.  Characterizing the Circulating Cell Populations in Traumatic Heterotopic Ossification.

Authors:  Shawn J Loder; Shailesh Agarwal; Michael T Chung; David Cholok; Charles Hwang; Noelle Visser; Kaetlin Vasquez; Michael Sorkin; Joe Habbouche; Hsiao H Sung; Joshua Peterson; David Fireman; Kavitha Ranganathan; Christopher Breuler; Caitlin Priest; John Li; Xue Bai; Shuli Li; Paul S Cederna; Benjamin Levi
Journal:  Am J Pathol       Date:  2018-08-22       Impact factor: 4.307

2.  NF-κB/MAPK activation underlies ACVR1-mediated inflammation in human heterotopic ossification.

Authors:  Emilie Barruet; Blanca M Morales; Corey J Cain; Amy N Ton; Kelly L Wentworth; Tea V Chan; Tania A Moody; Mariëlle C Haks; Tom Hm Ottenhoff; Judith Hellman; Mary C Nakamura; Edward C Hsiao
Journal:  JCI Insight       Date:  2018-11-15

Review 3.  Mechanisms of bone development and repair.

Authors:  Ankit Salhotra; Harsh N Shah; Benjamin Levi; Michael T Longaker
Journal:  Nat Rev Mol Cell Biol       Date:  2020-09-08       Impact factor: 94.444

Review 4.  Inflammation in Fibrodysplasia Ossificans Progressiva and Other Forms of Heterotopic Ossification.

Authors:  Koji Matsuo; Robert Dalton Chavez; Emilie Barruet; Edward C Hsiao
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

5.  Treponema denticola stimulates Oncostatin M cytokine release and de novo synthesis in neutrophils and macrophages.

Authors:  Megan M Jones; Stephen T Vanyo; Wael Ibraheem; Abhiram Maddi; Michelle B Visser
Journal:  J Leukoc Biol       Date:  2020-07-17       Impact factor: 4.962

6.  Inhibition of JAK1/2 Tyrosine Kinases Reduces Neurogenic Heterotopic Ossification After Spinal Cord Injury.

Authors:  Kylie A Alexander; Hsu-Wen Tseng; Whitney Fleming; Beulah Jose; Marjorie Salga; Irina Kulina; Susan M Millard; Allison R Pettit; François Genêt; Jean-Pierre Levesque
Journal:  Front Immunol       Date:  2019-03-07       Impact factor: 7.561

7.  Activation of Shc1 Allows Oncostatin M to Induce RANKL and Osteoclast Formation More Effectively Than Leukemia Inhibitory Factor.

Authors:  Emma Persson; Pedro P C Souza; Thais Floriano-Marcelino; Howard Herschel Conaway; Petra Henning; Ulf H Lerner
Journal:  Front Immunol       Date:  2019-05-28       Impact factor: 7.561

8.  Regulation of heterotopic ossification by monocytes in a mouse model of aberrant wound healing.

Authors:  Michael Sorkin; Amanda K Huber; Charles Hwang; William F Carson; Rajasree Menon; John Li; Kaetlin Vasquez; Chase Pagani; Nicole Patel; Shuli Li; Noelle D Visser; Yashar Niknafs; Shawn Loder; Melissa Scola; Dylan Nycz; Katherine Gallagher; Laurie K McCauley; Jiajia Xu; Aaron W James; Shailesh Agarwal; Stephen Kunkel; Yuji Mishina; Benjamin Levi
Journal:  Nat Commun       Date:  2020-02-05       Impact factor: 14.919

9.  Targeting local lymphatics to ameliorate heterotopic ossification via FGFR3-BMPR1a pathway.

Authors:  Dali Zhang; Junlan Huang; Xianding Sun; Hangang Chen; Shuo Huang; Jing Yang; Xiaolan Du; Qiaoyan Tan; Fengtao Luo; Ruobin Zhang; Siru Zhou; Wanling Jiang; Zhenhong Ni; Zuqiang Wang; Min Jin; Meng Xu; Fangfang Li; Liang Chen; Mi Liu; Nan Su; Xiaoqing Luo; Liangjun Yin; Ying Zhu; Jerry Q Feng; Di Chen; Huabing Qi; Lin Chen; Yangli Xie
Journal:  Nat Commun       Date:  2021-07-19       Impact factor: 14.919

10.  Muscle injury promotes heterotopic ossification by stimulating local bone morphogenetic protein-7 production.

Authors:  Yangzi Jiang; Hang Lin; He Shen; Jihee Sohn; Peter G Alexander; Rocky S Tuan
Journal:  J Orthop Translat       Date:  2019-07-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.